Virginia Cancer Specialists Appoints Dr. Etan R. Aber as Medical Oncologist to Enhance Research Institute
Virginia Cancer Specialists (VCS), the largest community cancer practice in Virginia, has made a significant addition to its team by welcoming Dr. Etan R. Aber, MD, PhD, as a medical oncologist at the Virginia Cancer Specialists Research Institute. This move aims to bolster the practice's already prominent clinical trials and precision oncology programs. Dr. Aber brings with him a wealth of experience and expertise that will enhance VCS's ability to provide cutting-edge cancer care to its patients.
Dr. Aber is a highly qualified medical oncologist and physician-scientist, recognized for his proficiency in precision oncology and clinical investigation. His extensive training began with the MD/PhD program at Columbia University, where he developed a strong foundation in both medical and scientific disciplines. Following this, Dr. Aber completed a residency in Internal Medicine and further honed his skills during his fellowship in Medical Oncology at the National Institutes of Health (NIH). Additionally, he graduated summa cum laude from the University of Pennsylvania, where he investigated the biological basis of behavior and led pioneering research in neuroscience.
Dr. Alexander I. Spira, Co-Director of the Virginia Cancer Specialists Research Institute, expressed enthusiasm about Dr. Aber's addition to the team. "Virginia Cancer Specialists has established one of the most robust community-based research programs in the Mid-Atlantic region," he said. Dr. Spira noted that Dr. Aber's strong background in translational research and precision medicine enhances the institute’s mission to deliver promising scientific advances to patients through clinical trials.
Throughout his career, Dr. Aber has focused on crucial research areas such as tumor biology, metastasis, and biomarker development. His contributions span various clinical trials that have tested targeted and novel therapeutic approaches; he has co-authored numerous scientific publications as well.
The Virginia Cancer Specialists Research Institute stands out as the largest oncology research program within the Mid-Atlantic region, providing patients with access to hundreds of clinical trials covering a diverse array of cancer types and genetic mutations. VCS’s unique model integrates research directly with clinical care, allowing eligible patients access to emerging therapies long before they reach the broader market while ensuring continuity of care with their established oncology team.
"Joining Virginia Cancer Specialists and its Research Institute is truly exciting for me," Dr. Aber remarked. "I was drawn to this role because it combines scientific discovery with compassionate, patient-centered healthcare, and offers an opportunity to expand access to clinical trials in the community."
In his role at VCS, Dr. Aber will care for patients at their Fairfax location, situated at 8613 US-29, Fairfax, VA 22031. He will actively participate in ongoing clinical trials and initiatives aimed at fostering collaboration across various specialties, including medical oncology, genetics, surgery, and research teams.
Virginia Cancer Specialists has gained recognition as the largest private cancer practice in Northern Virginia. It has been rated as the top medical practice for cancer care and across all specialties in Virginia for three consecutive years (2024-2026) by Castle Connolly Top Doctors. The practice boasts a top-tier treatment team and provides access to the latest treatment protocols targeting both cancer and blood diseases.
In addition to a rich portfolio of clinical trials—facilitated by a collaboration with NEXT Oncology—it features a dedicated research facility for Phase I and other advanced trials. The practice also offers comprehensive oncology services, including medical and radiation oncology, surgical interventions, genetic counseling, supportive cancer care, and telehealth solutions. Notably, Virginia Cancer Specialists is part of The US Oncology Network, which includes over 600 sites and more than 2,700 affiliated physicians, providing an extensive support system for cancer care across the country. The partnership with the esteemed Sara Cannon Research Institute further enhances the network’s ability to expand clinical studies and improve patient outcomes, contributing to breakthroughs in FDA-approved cancer therapies. To find out more about The US Oncology Network and Virginia Cancer Specialists, visit USOncology.com and VirginiaCancerSpecialists.com, respectively.
Dr. Aber is a highly qualified medical oncologist and physician-scientist, recognized for his proficiency in precision oncology and clinical investigation. His extensive training began with the MD/PhD program at Columbia University, where he developed a strong foundation in both medical and scientific disciplines. Following this, Dr. Aber completed a residency in Internal Medicine and further honed his skills during his fellowship in Medical Oncology at the National Institutes of Health (NIH). Additionally, he graduated summa cum laude from the University of Pennsylvania, where he investigated the biological basis of behavior and led pioneering research in neuroscience.
Dr. Alexander I. Spira, Co-Director of the Virginia Cancer Specialists Research Institute, expressed enthusiasm about Dr. Aber's addition to the team. "Virginia Cancer Specialists has established one of the most robust community-based research programs in the Mid-Atlantic region," he said. Dr. Spira noted that Dr. Aber's strong background in translational research and precision medicine enhances the institute’s mission to deliver promising scientific advances to patients through clinical trials.
Throughout his career, Dr. Aber has focused on crucial research areas such as tumor biology, metastasis, and biomarker development. His contributions span various clinical trials that have tested targeted and novel therapeutic approaches; he has co-authored numerous scientific publications as well.
The Virginia Cancer Specialists Research Institute stands out as the largest oncology research program within the Mid-Atlantic region, providing patients with access to hundreds of clinical trials covering a diverse array of cancer types and genetic mutations. VCS’s unique model integrates research directly with clinical care, allowing eligible patients access to emerging therapies long before they reach the broader market while ensuring continuity of care with their established oncology team.
"Joining Virginia Cancer Specialists and its Research Institute is truly exciting for me," Dr. Aber remarked. "I was drawn to this role because it combines scientific discovery with compassionate, patient-centered healthcare, and offers an opportunity to expand access to clinical trials in the community."
In his role at VCS, Dr. Aber will care for patients at their Fairfax location, situated at 8613 US-29, Fairfax, VA 22031. He will actively participate in ongoing clinical trials and initiatives aimed at fostering collaboration across various specialties, including medical oncology, genetics, surgery, and research teams.
Virginia Cancer Specialists has gained recognition as the largest private cancer practice in Northern Virginia. It has been rated as the top medical practice for cancer care and across all specialties in Virginia for three consecutive years (2024-2026) by Castle Connolly Top Doctors. The practice boasts a top-tier treatment team and provides access to the latest treatment protocols targeting both cancer and blood diseases.
In addition to a rich portfolio of clinical trials—facilitated by a collaboration with NEXT Oncology—it features a dedicated research facility for Phase I and other advanced trials. The practice also offers comprehensive oncology services, including medical and radiation oncology, surgical interventions, genetic counseling, supportive cancer care, and telehealth solutions. Notably, Virginia Cancer Specialists is part of The US Oncology Network, which includes over 600 sites and more than 2,700 affiliated physicians, providing an extensive support system for cancer care across the country. The partnership with the esteemed Sara Cannon Research Institute further enhances the network’s ability to expand clinical studies and improve patient outcomes, contributing to breakthroughs in FDA-approved cancer therapies. To find out more about The US Oncology Network and Virginia Cancer Specialists, visit USOncology.com and VirginiaCancerSpecialists.com, respectively.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.